Quarterly Appendix 4C Cash Flow Report
| Stock | Intelicare Holdings Ltd (ICR.ASX) |
|---|---|
| Release Time | 31 Jul 2025, 9:57 a.m. |
| Price Sensitive | Yes |
Intelicare Holdings Ltd Quarterly Cash Flow Report
- Cash receipts from customers of $235,000 in the current quarter
- Net cash used in operating activities of $564,000 in the current quarter
- Secured $1,000,000 in additional funding through convertible note and R&D loan
Intelicare Holdings Ltd has released its quarterly cash flow report for the period ended 30 June 2025. The report shows cash receipts from customers of $235,000 in the current quarter and net cash used in operating activities of $564,000. The company has also reported cash and cash equivalents of $412,000 at the end of the quarter. Intelicare has secured $1,000,000 in additional funding through a structured financing arrangement, consisting of a $600,000 convertible note facility and a $400,000 R&D loan. The company has drawn down the $400,000 R&D loan after the quarter end. Intelicare is continuing its process to reduce operating cash flows, and it is expected that the current level of cash flows will be maintained for the next two quarters. The company believes it will be able to continue its operations and meet its business objectives, and it will continue to evaluate options to raise further cash as needed.
The company is continuing its process to reduce operating cash flows, but it is expected that the current level of cash flows will be maintained for the next two quarters. Intelicare has secured $1,000,000 in additional funding through a structured financing arrangement and will continue to evaluate options to raise further cash as needed.